paediatrics Brussels 17

Data analysis and interpretation:

Iska Moxon-Emre, Michael D. Taylor,

Normand Laperriere, Donald Mabbott

Manuscript writing:

All authors

Final approval of manuscript:

All authors

REFERENCES

Pollack IF: Multidisciplinary management of

childhood brain tumors: A review of outcomes,

recent advances, and challenges. J Neurosurg Pedi-

atr 8:135-148, 2011

Mueller S, Chang S: Pediatric brain tumors:

Current treatment strategies and future therapeutic

approaches. Neurotherapeutics 6:570-586, 2009

Barrera M, Shaw AK, Speechley KN, et al:

Educational and social late effects of childhood

cancer and related clinical, personal, and familial

characteristics. Cancer 104:1751-1760, 2005

Mabbott DJ, Spiegler BJ, Greenberg ML, et

al: Serial evaluation of academic and behavioral

outcome after treatment with cranial radiation in

childhood. J Clin Oncol 23:2256-2263, 2005

Spiegler BJ, Bouffet E, Greenberg ML, et al:

Change in neurocognitive functioning after treat-

ment with cranial radiation in childhood. J Clin Oncol

22:706-713, 2004

Palmer SL, Gajjar A, Reddick WE, et al: Pre-

dicting intellectual outcome among children treated

with 35-40 Gy craniospinal irradiation for medullo-

blastoma. Neuropsychology 17:548-555, 2003

Ris MD, Packer R, Goldwein J, et al: Intellec-

tual outcome after reduced-dose radiation therapy

plus adjuvant chemotherapy for medulloblastoma: A

Children’s Cancer Group study. J Clin Oncol 19:

3470-3476, 2001

Roncadin C, Dennis M, Greenberg ML, et al:

Adverse medical events associated with childhood

cerebellar astrocytomas and medulloblastomas:

Natural history and relation to very long-term neu-

robehavioral outcome. Childs Nerv Syst 24:995-

1002, 2008; discussion 1003

Merchant TE, Kun LE, Krasin MJ, et al: Multi-

institution prospective trial of reduced-dose cranio-

spinal irradiation (23.4 Gy) followed by conformal

posterior fossa (36 Gy) and primary site irradiation

(55.8 Gy) and dose-intensive chemotherapy for

average-risk medulloblastoma. Int J Radiat Oncol

Biol Phys 70:782-787, 2008

10.

Grill J, Renaux VK, Bulteau C, et al: Long-term

intellectual outcome in children with posterior fossa

tumors according to radiation doses and volumes.

Int J Radiat Oncol Biol Phys 45:137-145, 1999

11.

Kieffer-Renaux V, Bulteau C, Grill J, et al:

Patterns of neuropsychological deficits in children

with medulloblastoma according to craniospatial ir-

radiation doses. Dev Med Child Neurol 42:741-745,

2000

12.

Mulhern RK, Kepner JL, Thomas PR, et al:

Neuropsychologic functioning of survivors of child-

hood medulloblastoma randomized to receive con-

ventional or reduced-dose craniospinal irradiation: A

Pediatric Oncology Group study. J Clin Oncol 16:

1723-1728, 1998

13.

Mabbott DJ, Penkman L, Witol A, et al: Core

neurocognitive functions in children treated for pos-

terior fossa tumors. Neuropsychology 22:159-168,

2008

14.

Ris MD, Walsh K, Wallace D, et al: Intellectual

and academic outcome following two chemotherapy

regimens and radiotherapy for average-risk medullo-

blastoma: COG A9961. Pediatr Blood Cancer 60:1350-

1357, 2013

15.

Wolden SL, Dunkel IJ, Souweidane MM, et al:

Patterns of failure using a conformal radiation ther-

apy tumor bed boost for medulloblastoma. J Clin

Oncol 21:3079-3083, 2003

16.

Mulhern RK, Palmer SL, Merchant TE, et al:

Neurocognitive consequences of risk-adapted ther-

apy for childhood medulloblastoma. J Clin Oncol

23:5511-5519, 2005

17.

Van Calenbergh F, Van de Laar A, Plets C, et

al: Transient cerebellar mutism after posterior fossa

surgery in children. Neurosurgery 37:894-898, 1995

18.

Hardy KK, Bonner MJ, Willard VW, et al:

Hydrocephalus as a possible additional contributor

to cognitive outcome in survivors of pediatric me-

dulloblastoma. Psychooncology 17:1157-1161, 2008

19.

Merchant TE, Lee H, Zhu J, et al: The effects

of hydrocephalus on intelligence quotient in children

with localized infratentorial ependymoma before

and after focal radiation therapy. J Neurosurg 101:

159-168, 2004 (suppl)

20.

Palmer SL, Hassall T, Evankovich K, et al:

Neurocognitive outcome 12 months following cere-

bellar mutism syndrome in pediatric patients with

medulloblastoma. Neuro Oncol 12:1311-1317, 2010

21.

Erickson K, Baron IS, Fantie BD: Neuropsy-

chological functioning in early hydrocephalus: Re-

view from a developmental perspective. Child

Neuropsychol 7:199-229, 2001

22.

Conklin HM, Li C, Xiong X, et al: Predicting

change in academic abilities after conformal radia-

tion therapy for localized ependymoma. J Clin Oncol

26:3965-3970, 2008

23.

Merchant TE, Kiehna EN, Kun LE, et al: Phase

II trial of conformal radiation therapy for pediatric

patients with craniopharyngioma and correlation of

surgical factors and radiation dosimetry with change

in cognitive function. J Neurosurg 104:94-102, 2006

(suppl)

24.

Merchant TE, Conklin HM, Wu S, et al: Late

effects of conformal radiation therapy for pediatric

patients with low-grade glioma: Prospective evalua-

tion of cognitive, endocrine, and hearing deficits.

J Clin Oncol 27:3691-3697, 2009

25.

Di Pinto M, Conklin HM, Li C, et al: Investi-

gating verbal and visual auditory learning after con-

formal radiation therapy for childhood ependymoma.

Int J Radiat Oncol Biol Phys 77:1002-1008, 2010

26.

Wechsler D: Wechsler Intelligence Scale for

Children (ed 4). San Antonio, TX, Psychological Cor-

poration, 2003

27.

Palmer RF, Royall DR: Missing data? Plan on

it! J Am Geriatr Soc 58:S343-S348, 2010 (suppl 2)

28.

Crawford JR, MacDonald TJ, Packer RJ: Me-

dulloblastoma in childhood: New biological ad-

vances. Lancet Neurol 6:1073-1085, 2007

29.

Del Bigio MR: Neuropathological changes

caused by hydrocephalus. Acta Neuropathol 85:573-

585, 1993

30.

Gopalakrishnan CV, Dhakoji A, Menon G, et al:

Factors predicting the need for cerebrospinal fluid

diversion following posterior fossa tumor surgery in

children. Pediatr Neurosurg 48:93-101, 2012

31.

Law N, Greenberg M, Bouffet E, et al: Clinical

and neuroanatomical predictors of cerebellar mut-

ism syndrome. Neuro Oncol 14:1294-1303, 2012

32.

Taylor MD, Northcott PA, Korshunov A, et al:

Molecular subgroups of medulloblastoma: The cur-

rent consensus. Acta Neuropathol 123:465-472,

2012

■ ■ ■

Moxon-Emre et al

1768

OURNAL OF

LINICAL

NCOLOGY

2015 from 139.18.235.208

Information downloaded from

jco.ascopubs.org

and provided by at UNIVERSITAETSKLINIKUM LEIPZIG on February 17,